- List
- By Topic
- On Map
- Search Details

vitamine D | Pancreatic Cancer | United States
Need help? See RSS Feeds
Choose a feed type:

vitamine D | Pancreatic Cancer | United States (10 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01327794 | Completed | Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer |
|
|
Observational |
|
Other / NIH |
|
|
265 | All | 18 Years and older (Adult, Older Adult) | NCT01327794 | CALGB-151006 U10CA031946 CDR0000698059 |
June 2011 | August 2014 | August 2014 | April 4, 2011 | June 29, 2016 |
|
||||
2 | NCT03520790 | Recruiting | Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
112 | All | 18 Years and older (Adult, Older Adult) | NCT03520790 | 18-021 | December 5, 2018 | November 30, 2021 | November 30, 2025 | May 10, 2018 | February 8, 2019 |
|
|||
3 | NCT03331562 | Recruiting | A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
24 | All | 18 Years and older (Adult, Older Adult) | NCT03331562 | TGen 17-001 MISP# 56240 |
December 27, 2017 | May 15, 2019 | December 15, 2019 | November 6, 2017 | September 19, 2018 |
|
|||
4 | NCT03300921 | Recruiting | A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03300921 | UPCC 26217 | September 28, 2017 | March 28, 2019 | May 28, 2019 | October 4, 2017 | October 31, 2017 |
|
|||
5 | NCT03519308 | Recruiting | A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Micoenvironment in Resectable Pancreatic Cancer |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03519308 | UPCC 22217 | August 4, 2017 | April 4, 2019 | August 4, 2019 | May 8, 2018 | May 8, 2018 |
|
|||
6 | NCT02030860 | Active, not recruiting | A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Older Adult) | NCT02030860 | UPCC 23213 | January 2014 | December 2015 | January 9, 2014 | August 21, 2018 |
|
||||
7 | NCT02336087 | Recruiting | Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
|
21 | All | 18 Years and older (Adult, Older Adult) | NCT02336087 | 14122 NCI-2014-02612 |
January 2016 | August 2019 | August 2019 | January 12, 2015 | November 19, 2018 |
|
|||
8 | NCT03415854 | Recruiting | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
14 | All | 18 Years and older (Adult, Older Adult) | NCT03415854 | SU2C HRI NPG-001 | NABPLAGEMD | January 31, 2018 | July 15, 2020 | December 15, 2020 | January 30, 2018 | July 18, 2018 |
|
||
9 | NCT00954525 | Completed | Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
14 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00954525 | 09D.99 | July 2009 | December 2011 | December 2011 | August 7, 2009 | June 20, 2018 |
|
|||
10 | NCT01555489 | Terminated Has Results |
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
11 | All | 18 Years and older (Adult, Older Adult) | NCT01555489 | 11D.365 | October 2011 | January 2016 | January 2016 | March 15, 2012 | August 28, 2018 | August 28, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.